{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:26:58Z","timestamp":1783423618433,"version":"3.54.6"},"reference-count":60,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:00:00Z","timestamp":1756512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"U.S. Department of Agriculture, National Institute of Food and Agriculture, Agriculture and Food Research Initiative","award":["2020-06448"],"award-info":[{"award-number":["2020-06448"]}]},{"name":"U.S. Department of Agriculture, National Institute of Food and Agriculture, Agriculture and Food Research Initiative","award":["2024-08723"],"award-info":[{"award-number":["2024-08723"]}]},{"name":"U.S. Department of Agriculture, National Institute of Food and Agriculture, Agriculture and Food Research Initiative","award":["1R01AI147109"],"award-info":[{"award-number":["1R01AI147109"]}]},{"name":"National Institutes of Health\u2013NIAID","award":["2020-06448"],"award-info":[{"award-number":["2020-06448"]}]},{"name":"National Institutes of Health\u2013NIAID","award":["2024-08723"],"award-info":[{"award-number":["2024-08723"]}]},{"name":"National Institutes of Health\u2013NIAID","award":["1R01AI147109"],"award-info":[{"award-number":["1R01AI147109"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background\/Objectives: The continued evolution and cross-species transmission of clade 2.3.4.4b H5Nx highly pathogenic avian influenza (HPAI) viruses underscores the need for broadly protective vaccines in swine, a key intermediary host. This study aimed to evaluate systemic and mucosal immune responses elicited by adenoviral-vectored (Ad) vaccines encoding a centralized consensus hemagglutinin antigen (H5CC) in mice and swine. Methods: We constructed H5CC-based vaccines that were delivered using replication-defective (Ad5 and Ad6) and replication-competent (Ad28 and Ad48) human adenoviral vectors. Using a serotype-switched prime-boost strategy, vaccines were delivered intramuscularly (IM) or intranasally (IN) in mice and swine. We determined humoral, mucosal, and cell-mediated immune responses by hemagglutination inhibition (HI), microneutralization assay (MNA), ELISA, and IFN-\u03b3 ELISpot. Protective efficacy was evaluated by lethal H5N1 challenge in mice. Results: All vaccine strategies and routes induced significant levels of anti-H5 immunity. Ad5\/Ad6 IM immunization elicited strong systemic IgG and MNA titers and robust T cell responses. IN delivery with Ad5\/Ad6 induced superior mucosal IgA levels in lungs and nasal secretion. In swine, Ad5\/Ad6 IM conferred the highest MNA titer and T cell responses, while the IN route enhanced mucosal IgA. The Ad28\/Ad48 vaccines induced immunity in a similar pattern as compared to the Ad5\/Ad6 strategy, but to a slightly lesser degree, in general. The commercial H1\/H3 swine influenza vaccine failed to elicit cross-protective immunity. All H5CC vaccinated mice survived lethal H5N1 challenge without weight loss. Conclusions: Adenoviral-vectored H5CC vaccines elicit broad, cross-clade immunity with route-dependent immune profiles. IM vaccination is optimal for systemic and cellular responses, while IN delivery enhances mucosal immunity. These findings support the advancement of adenoviral platforms for influenza control in swine and pandemic preparedness.<\/jats:p>","DOI":"10.3390\/vaccines13090928","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T16:05:22Z","timestamp":1756829122000},"page":"928","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Systemic and Mucosal Immune Responses Induced by Adenoviral-Vectored Consensus H5 Influenza A Vaccines in Mice and Swine"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4007-4920","authenticated-orcid":false,"given":"Adthakorn","family":"Madapong","sequence":"first","affiliation":[{"name":"Nebraska Center for Virology, University of Nebraska-Lincoln, Lincoln, NE 68583, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8574-5073","authenticated-orcid":false,"given":"Joshua","family":"Wiggins","sequence":"additional","affiliation":[{"name":"Nebraska Center for Virology, University of Nebraska-Lincoln, Lincoln, NE 68583, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"DeBeauchamp","sequence":"additional","affiliation":[{"name":"St. Jude Children\u2019s Research Hospital, Memphis, TN 38105, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4397-7132","authenticated-orcid":false,"given":"Richard J.","family":"Webby","sequence":"additional","affiliation":[{"name":"St. Jude Children\u2019s Research Hospital, Memphis, TN 38105, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5029-0662","authenticated-orcid":false,"given":"Eric A.","family":"Weaver","sequence":"additional","affiliation":[{"name":"Nebraska Center for Virology, University of Nebraska-Lincoln, Lincoln, NE 68583, USA"},{"name":"School of Biological Sciences, University of Nebraska-Lincoln, Lincoln, NE 68583, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"110602","DOI":"10.1016\/j.virol.2025.110602","article-title":"Highly pathogenic avian influenza A (H5N1) virus outbreaks in South America in 2022\u20132024: A comprehensive review of an ongoing panzootic","volume":"610","author":"Bruno","year":"2025","journal-title":"Virology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"20814","DOI":"10.1073\/pnas.2001813117","article-title":"Genesis and spread of multiple reassortants during the 2016\/2017 H5 avian influenza epidemic in Eurasia","volume":"117","author":"Lycett","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s12250-016-3750-4","article-title":"Highly pathogenic avian influenza H5N1 Clade 2.3.2.1c virus in migratory birds, 2014\u20132015","volume":"31","author":"Bi","year":"2016","journal-title":"Virol. Sin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.3201\/eid2410.171891","article-title":"Transmission Dynamics of Highly Pathogenic Avian Influenza Virus A(H5Nx) Clade 2.3.4.4, North America, 2014\u20132015","volume":"24","author":"Lee","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.3201\/eid2906.221723","article-title":"Novel Avian Influenza Virus (H5N1) Clade 2.3.4.4b Reassortants in Migratory Birds, China","volume":"29","author":"Yang","year":"2023","journal-title":"Emerg. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Guilfoyle, K., Mirolo, M., de Waal, L., van Amerongen, G., van der Net, G., Stork, T., Lombardo, M.S., Baumgartner, W., Bjarnason, A., and Johannsdottir, H.B. (2025). Highly Pathogenic Avian Influenza Virus A\/H5N1 subclade 2.3.4.4 b isolated from a European grey seal (Halichoerus grypus) is highly virulent in ferrets. J. Infect. Dis., Online ahead of print.","DOI":"10.1093\/infdis\/jiaf348"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.15585\/mmwr.mm7405a2","article-title":"Highly Pathogenic Avian Influenza A(H5N1) Virus Infection of Indoor Domestic Cats Within Dairy Industry Worker Households\u2014Michigan, May 2024","volume":"74","author":"Naraharisetti","year":"2025","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.3201\/eid3106.241862","article-title":"Highly Pathogenic Avian Influenza A(H5N1) in Wild Birds and a Human, British Columbia, Canada, 2024","volume":"31","author":"Himsworth","year":"2025","journal-title":"Emerg. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.3168\/jdsc.2024-0650","article-title":"Hot topic: Epidemiological and clinical aspects of highly pathogenic avian influenza H5N1 in dairy cattle","volume":"5","author":"Rodriguez","year":"2024","journal-title":"JDS Commun."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1007\/s10096-025-05147-z","article-title":"The emergence of highly pathogenic avian influenza H5N1 in dairy cattle: Implications for public health, animal health, and pandemic preparedness","volume":"44","author":"Kamel","year":"2025","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/zph.12049","article-title":"Review of influenza A virus in swine worldwide: A call for increased surveillance and research","volume":"61","author":"Vincent","year":"2014","journal-title":"Zoonoses Public Health"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"7367","DOI":"10.1128\/JVI.72.9.7367-7373.1998","article-title":"Molecular basis for the generation in pigs of influenza A viruses with pandemic potential","volume":"72","author":"Ito","year":"1998","journal-title":"J. Virol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Nelli, R.K., Kuchipudi, S.V., White, G.A., Perez, B.B., Dunham, S.P., and Chang, K.C. (2010). Comparative distribution of human and avian type sialic acid influenza receptors in the pig. BMC Vet. Res., 6.","DOI":"10.1186\/1746-6148-6-4"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3201\/eid3004.231141","article-title":"Divergent Pathogenesis and Transmission of Highly Pathogenic Avian Influenza A(H5N1) in Swine","volume":"30","author":"Arruda","year":"2024","journal-title":"Emerg. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2353292","DOI":"10.1080\/22221751.2024.2353292","article-title":"Pigs are highly susceptible to but do not transmit mink-derived highly pathogenic avian influenza virus H5N1 clade 2.3.4.4b","volume":"13","author":"Kwon","year":"2024","journal-title":"Emerg. Microbes Infect."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"110231","DOI":"10.1016\/j.virol.2024.110231","article-title":"Susceptibilities and viral shedding of peridomestic wildlife infected with clade 2.3.4.4b highly pathogenic avian influenza virus (H5N1)","volume":"600","author":"Root","year":"2024","journal-title":"Virology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e01323-18","DOI":"10.1128\/JVI.01323-18","article-title":"Comparison of Adjuvanted-Whole Inactivated Virus and Live-Attenuated Virus Vaccines against Challenge with Contemporary, Antigenically Distinct H3N2 Influenza A Viruses","volume":"92","author":"Abente","year":"2018","journal-title":"J. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1099\/jgv.0.000468","article-title":"Vaccine-associated enhanced respiratory disease is influenced by haemagglutinin and neuraminidase in whole inactivated influenza virus vaccines","volume":"97","author":"Rajao","year":"2016","journal-title":"J. Gen. Virol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.virol.2014.10.003","article-title":"Live attenuated influenza A virus vaccine protects against A(H1N1)pdm09 heterologous challenge without vaccine associated enhanced respiratory disease","volume":"471\u2013473","author":"Gauger","year":"2014","journal-title":"Virology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1177\/0300985812439724","article-title":"Kinetics of lung lesion development and pro-inflammatory cytokine response in pigs with vaccine-associated enhanced respiratory disease induced by challenge with pandemic (2009) A\/H1N1 influenza virus","volume":"49","author":"Gauger","year":"2012","journal-title":"Vet. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1128\/JVI.02696-06","article-title":"Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D","volume":"81","author":"Abbink","year":"2007","journal-title":"J. Virol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/mt.2009.130","article-title":"New insights on adenovirus as vaccine vectors","volume":"17","author":"Lasaro","year":"2009","journal-title":"Mol. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"544","DOI":"10.4161\/hv.27238","article-title":"Vaccines within vaccines: The use of adenovirus types 4 and 7 as influenza vaccine vectors","volume":"10","author":"Weaver","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Weaver, E.A., Nehete, P.N., Nehete, B.P., Yang, G., Buchl, S.J., Hanley, P.W., Palmer, D., Montefiori, D.C., Ferrari, G., and Ng, P. (2013). Comparison of Systemic and Mucosal Immunization with Helper-Dependent Adenoviruses for Vaccination against Mucosal Challenge with SHIV. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0067574"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Weaver, E.A., Rubrum, A.M., Webby, R.J., and Barry, M.A. (2011). Protection against divergent influenza H1N1 virus by a centralized influenza hemagglutinin. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0018314"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1128\/CVI.00144-09","article-title":"Safety and immunogenicity of the Merck adenovirus serotype 5 (MRKAd5) and MRKAd6 human immunodeficiency virus type 1 trigene vaccines alone and in combination in healthy adults","volume":"16","author":"Harro","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1089\/hum.2013.215","article-title":"CD46-mediated transduction of a species D adenovirus vaccine improves mucosal vaccine efficacy","volume":"25","author":"Camacho","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.vetmic.2016.11.026","article-title":"Influenza A virus vaccines for swine","volume":"206","author":"Vincent","year":"2017","journal-title":"Vet. Microbiol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Tizard, I.R. (2021). Porcine vaccines. Vaccines for Veterinarians, Elsevier.","DOI":"10.1016\/B978-0-323-68299-2.00027-7"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"8607","DOI":"10.1128\/JVI.00159-10","article-title":"Adaptation of pandemic H1N1 influenza viruses in mice","volume":"84","author":"Ilyushina","year":"2010","journal-title":"J. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Lingel, A., Bullard, B.L., and Weaver, E.A. (2017). Efficacy of an Adenoviral Vectored Multivalent Centralized Influenza Vaccine. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-14891-y"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Webby, R.J., and Weaver, E.A. (2015). Centralized Consensus Hemagglutinin Genes Induce Protective Immunity against H1, H3 and H5 Influenza Viruses. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0140702"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Weaver, E.A., and Barry, M.A. (2013). Low seroprevalent species D adenovirus vectors as influenza vaccines. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0073313"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1038\/s41467-025-59182-7","article-title":"Epitope-optimized vaccine elicits enduring immunity against swine influenza A virus","volume":"16","author":"Madapong","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_35","first-page":"158","article-title":"The pig as a mixing vessel for influenza viruses: Human and veterinary implications","volume":"3","author":"Ma","year":"2008","journal-title":"J. Mol. Genet. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1297-9716-44-72","article-title":"Dynamics of influenza A virus infections in permanently infected pig farms: Evidence of recurrent infections, circulation of several swine influenza viruses and reassortment events","volume":"44","author":"Rose","year":"2013","journal-title":"Vet. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nature08182","article-title":"Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic","volume":"459","author":"Smith","year":"2009","journal-title":"Nature"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/irv.12463","article-title":"Absence of clinical disease and contact transmission of HPAI H5NX clade 2.3.4.4 from North America in experimentally infected pigs","volume":"11","author":"Kaplan","year":"2017","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0378-1135(00)00172-3","article-title":"Systemic and mucosal immune responses to H1N1 influenza virus infection in pigs","volume":"74","author":"Larsen","year":"2000","journal-title":"Vet. Microbiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"6696","DOI":"10.1038\/ncomms7696","article-title":"Global migration of influenza A viruses in swine","volume":"6","author":"Nelson","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41541-022-00492-y","article-title":"An epitope-optimized human H3N2 influenza vaccine induces broadly protective immunity in mice and ferrets","volume":"7","author":"Bullard","year":"2022","journal-title":"npj Vaccines"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"6290","DOI":"10.4049\/jimmunol.172.10.6290","article-title":"Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity","volume":"172","author":"Barouch","year":"2004","journal-title":"J. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.3390\/v4112711","article-title":"Advances and future challenges in recombinant adenoviral vectored H5N1 influenza vaccines","volume":"4","author":"Zhang","year":"2012","journal-title":"Viruses"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Verschoor, C.P., Singh, P., Russell, M.L., Bowdish, D.M., Brewer, A., Cyr, L., Ward, B.J., and Loeb, M. (2015). Microneutralization assay titres correlate with protection against seasonal influenza H1N1 and H3N2 in children. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0131531"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/s41467-021-21954-2","article-title":"A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodies","volume":"12","author":"Creanga","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Hu, Z., Zhao, J., Zhao, Y., Fan, X., Hu, J., Shi, L., Wang, X., Liu, X., Hu, S., and Gu, M. (2019). Hemagglutinin-Specific Non-neutralizing Antibody Is Essential for Protection Provided by Inactivated and Viral-Vectored H7N9 Avian Influenza Vaccines in Chickens. Front. Vet. Sci., 6.","DOI":"10.3389\/fvets.2019.00482"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Linnik, J., Syedbasha, M., Hollenstein, Y., Halter, J., Egli, A., and Stelling, J. (2022). Model-based inference of neutralizing antibody avidities against influenza virus. PLoS Pathog., 18.","DOI":"10.1371\/journal.ppat.1010243"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Waldock, J., Remarque, E.J., Zheng, L., Ho, S., Hoschler, K., Neumann, B., Sediri-Schon, H., Trombetta, C.M., Montomoli, E., and Marchi, S. (2023). Haemagglutination inhibition and virus microneutralisation serology assays: Use of harmonised protocols and biological standards in seasonal influenza serology testing and their impact on inter-laboratory variation and assay correlation: A FLUCOP collaborative study. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1155552"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11427-018-9439-0","article-title":"Glycosylation and an amino acid insertion in the head of hemagglutinin independently affect the antigenic properties of H5N1 avian influenza viruses","volume":"62","author":"Gu","year":"2019","journal-title":"Sci. China Life Sci."},{"key":"ref_50","first-page":"55833","article-title":"An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers","volume":"2017","author":"Kaufmann","year":"2017","journal-title":"J. Vis. Exp."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e0095321","DOI":"10.1128\/msphere.00953-21","article-title":"Interlaboratory Reproducibility of Standardized Hemagglutination Inhibition Assays","volume":"7","author":"Bibby","year":"2022","journal-title":"mSphere"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Zhou, F., Hansen, L., Pedersen, G., Grodeland, G., and Cox, R. (2021). Matrix M Adjuvanted H5N1 Vaccine Elicits Broadly Neutralizing Antibodies and Neuraminidase Inhibiting Antibodies in Humans That Correlate With In Vivo Protection. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.747774"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/infdis\/jiv195","article-title":"Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection","volume":"212","author":"Monto","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Holzer, B., Martini, V., Edmans, M., and Tchilian, E. (2019). T and B Cell Immune Responses to Influenza Viruses in Pigs. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00098"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1128\/CVI.00315-12","article-title":"Intranasal vaccination with replication-defective adenovirus type 5 encoding influenza virus hemagglutinin elicits protective immunity to homologous challenge and partial protection to heterologous challenge in pigs","volume":"19","author":"Braucher","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.dci.2008.07.018","article-title":"Induction of mucosal immunity in the avian Harderian gland with a replication-deficient Ad5 vector expressing avian influenza H5 hemagglutinin","volume":"33","author":"Tang","year":"2009","journal-title":"Dev. Comp. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.4161\/hv.29594","article-title":"Pre-existing immunity against Ad vectors: Humoral, cellular, and innate response, what\u2019s important?","volume":"10","author":"Kobinger","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ymthe.2004.07.013","article-title":"Adenoviruses as vaccine vectors","volume":"10","author":"Tatsis","year":"2004","journal-title":"Mol. Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.vetmic.2006.07.014","article-title":"Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus","volume":"118","author":"Wesley","year":"2006","journal-title":"Vet. Microbiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41577-020-00436-4","article-title":"Not just antibodies: B cells and T cells mediate immunity to COVID-19","volume":"20","author":"Cox","year":"2020","journal-title":"Nat. Rev. Immunol."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/9\/928\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:36:15Z","timestamp":1760034975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/9\/928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,30]]},"references-count":60,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["vaccines13090928"],"URL":"https:\/\/doi.org\/10.3390\/vaccines13090928","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,30]]}}}